US › Healthcare

Accuray Incorporated (ARAY)

US · Healthcare · Medical Devices

$0.31+15.34%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$104.8M
Revenue YoY
-7.4%
Net profit
$-11.8M
Profit YoY
-810.2%
EPS
$-0.07
EPS estimate
$-0.05
Net margin
-11.3%

EPS came in at -0.07 against a street estimate of -0.05 — a miss of 40.0%.

Key statistics

Market cap
$32.0M
Forward P/E
94.3
P/B
0.77
Book value
$0.35
EPS (TTM)
$-0.38
52-week high
$2.10
52-week low
$0.22
50-day MA
$0.30
200-day MA
$0.65
Beta
1.39

Analyst view

Analysts rate Accuray Incorporated a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $0.35.

Shareholding

Insiders
4.34%
Institutions
69.14%

Largest institutional holders

FundStake
TCW Group Inc12.95%
BlackRock Inc7.08%
Neuberger Berman Group LLC4.90%
Armistice Capital, LLC4.72%
Weber Capital Management LLC4.23%
Vanguard Capital Management, LLC3.71%
Geode Capital Management, LLC1.99%
Mackenzie Investments1.96%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Accuray Incorporated — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.